跳至主要内容
临床试验/ACTRN12621001345875
ACTRN12621001345875尚未招募未知

Clinical outcomes of an eHealth-facilitated model of type 2 diabetes care in regional, rural and remote populations: The REMODeL-R3 trial

niversity of Queensland0 个研究点目标入组 112 人开始时间: 2021年10月7日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • People living with type 2 diabetes, attending the PA diabetes telehealth service:
  • with a glycated haemoglobin (HbA1c) >8%,
  • with an age >=18 years,
  • with pre-existing type 2 diabetes for at least 6 months, and
  • on insulin.

排除标准

  • The exclusion criteria will be participants
  • those referred to conventional IDA
  • those using the insulin pump, flash glucose monitoring or continuous glucose monitoring devices,
  • with a recent bariatric surgery of less than 12 months,
  • unable to communicate in English,
  • who are pregnant or those planning pregnancy in the next 12 months,
  • on insulin Ryzodeg
  • those who do not have a reliable internet connection (either through Wi-fi at home or 3G/4G).

研究者

发起方
niversity of Queensland

相似试验